Infections: Clostridium Difficile Infection

From UrologySchool.com
Revision as of 12:22, 4 November 2022 by Urology4all (talk | contribs) (Created page with "== Epidemiology == * Incidence is increasing with a preponderance of the NAP1 hypervirulent strain of C. difficile found in recent epidemics. ** The NAP1 strain is more likely to cause severe and fulminant colitis, characterized by marked leukocytosis, renal failure, hemodynamic instability, and toxic megacolon. ** It is believed the NAP1 strain arose due to the widespread use of fluoroquinolone antibiotics. == Management == * '''Options:''' *# '''Oral vancomycin (mor...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Epidemiology[edit | edit source]

  • Incidence is increasing with a preponderance of the NAP1 hypervirulent strain of C. difficile found in recent epidemics.
    • The NAP1 strain is more likely to cause severe and fulminant colitis, characterized by marked leukocytosis, renal failure, hemodynamic instability, and toxic megacolon.
    • It is believed the NAP1 strain arose due to the widespread use of fluoroquinolone antibiotics.

Management[edit | edit source]

  • Options:
    1. Oral vancomycin (more effective)
    2. Oral metronidazole
  • Neither I.V. vancomycin nor I.V. metronidazole have been found to be more effective than the oral form of the medications for treatment of CDI.
  • No role for fluoroquinolones.
  • Metronidazole should be avoided in patients on warfarin
    • Metronidazole interferes with warfarin metabolism
  • Worsening diarrhea, fever, and leukocytosis despite appropriate antibiotics is an absolute indication for surgical consultation.
    • Subtotal colectomy with end ileostomy is the procedure of choice for fulminant CD colitis nonresponsive to medications and has been documented to result in improved survival.

Questions[edit | edit source]

Answers[edit | edit source]

References[edit | edit source]

  • Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, vol 2, chap 12